DOMAIN 10: Evidence-based Practices
PAGE 12 of 14
View Table of Contents ›
Key
(S) = State HD (T) = Tribal HD (L) = Local HD
(S/T) = State/Tribal HD (T/L) = Tribal/Local HD (HAI/AR) = Healthcare Associated Infections/Antibiotic Resistance
PHAB Measures
PHAB Measures
HAI/AR Specific Programs or Activities
HAI/AR Specific Programs or Activities
Opportunities / Considerations For Connections Between HAI/AR and Accreditation
Opportunities / Considerations For Connections Between HAI/AR and Accreditation
Measure 10.1.1:
(All) Applicable evidence-based and/or promising practices identified and used when implementing new or revised processes, programs, and/or interventions
Measure 10.1.1:
(All) Applicable evidence-based and/or promising practices identified and used when implementing new or revised processes, programs, and/or interventions
HAI/AR Programs are expected to use CDC HAI/AR infection detection and prevention guidelines or evidence based science to drive public health action, implement and evaluate epidemiologic public health practice and prevention and control strategies.
HAI/AR Programs are expected to use CDC HAI/AR infection detection and prevention guidelines or evidence based science to drive public health action, implement and evaluate epidemiologic public health practice and prevention and control strategies.
Context: HDs must provide 2 examples of evidence-based or promising practices in a public health process, program or intervention, that have occurred in the past 3 years and come from 2 different program areas.
Opportunity: HAI/AR Programs may provide documentation of HAI/AR information and evidence-based or promising practices used.
Context: HDs must provide 2 examples of evidence-based or promising practices in a public health process, program or intervention, that have occurred in the past 3 years and come from 2 different program areas.
Opportunity: HAI/AR Programs may provide documentation of HAI/AR information and evidence-based or promising practices used.
Measure 10.1.2:
(ST) Fostered innovation in practice and research
Measure 10.1.2:
(ST) Fostered innovation in practice and research
HAI/AR Programs are expected to collaborate with local HDs, academic institutions, federal agencies, and public health and clinical laboratories on HAI and AR research and incorporate findings and best practices. Programs are encouraged to collaborate with healthcare facilities to improve infection control and prevention practice and with the academic partners and CDC’s Prevention Epicenters and EIPs to develop and evaluate HAI interventions and best practices.
HAI/AR Programs are expected to collaborate with local HDs, academic institutions, federal agencies, and public health and clinical laboratories on HAI and AR research and incorporate findings and best practices. Programs are encouraged to collaborate with healthcare facilities to improve infection control and prevention practice and with the academic partners and CDC’s Prevention Epicenters and EIPs to develop and evaluate HAI interventions and best practices.
Context: HDs are expected to have relationships with academic centers/institutes and engage in the work of the research community.
Opportunity: HAI/AR Programs may have formal or working (informal) relationships (e.g., pilot studies, proof of concept approaches) with academic institutions or research centers.
Context: HDs are expected to have relationships with academic centers/institutes and engage in the work of the research community.
Opportunity: HAI/AR Programs may have formal or working (informal) relationships (e.g., pilot studies, proof of concept approaches) with academic institutions or research centers.
PHAB Measures
PHAB Measures
HAI/AR Specific Programs or Activities
HAI/AR Specific Programs or Activities
Opportunities / Considerations For Connections Between HAI/AR and Accreditation
Opportunities / Considerations For Connections Between HAI/AR and Accreditation
Measure 10.2.1:
(All) Protection of human subjects when the HD is involved in or supports research activities
Measure 10.2.1:
(All) Protection of human subjects when the HD is involved in or supports research activities
n/a
n/a
n/a
n/a
Measure 10.2.2:
(All) Access to expertise to analyze current research and its public health implications
Measure 10.2.2:
(All) Access to expertise to analyze current research and its public health implications
n/a
n/a
n/a
n/a
Measure 10.2.3:
(All) Communicated research findings, including public health implications
Measure 10.2.3:
(All) Communicated research findings, including public health implications
HAI/AR Programs are expected to collaborate with local HDs, academic institutions, other federal agencies, and public health and clinical laboratories on HAI/AR research and communicate findings and best practices. HAI/AR Programs are encouraged to collaborate with the academic partners and CDC’s Prevention Epicenters and Emerging Infections Programs to develop and evaluate HAI interventions and best practices and communicate evidence based science to the public health, healthcare and public audiences.
HAI/AR Programs are expected to collaborate with local HDs, academic institutions, other federal agencies, and public health and clinical laboratories on HAI/AR research and communicate findings and best practices. HAI/AR Programs are encouraged to collaborate with the academic partners and CDC’s Prevention Epicenters and Emerging Infections Programs to develop and evaluate HAI interventions and best practices and communicate evidence based science to the public health, healthcare and public audiences.
Context: HDs must provide 2 examples of communication, conveying research findings and their implications to stakeholders, LHDs, public health system partners, etc. – can be by report, presentation, webinar, etc.
Opportunity: HAI/AR Programs may contribute to this measure by sharing documentation of reports or publications via email, presentation or webinar that present data or research findings from academic partners or other research that indicate findings that might affect public health.
Context: HDs must provide 2 examples of communication, conveying research findings and their implications to stakeholders, LHDs, public health system partners, etc. – can be by report, presentation, webinar, etc.
Opportunity: HAI/AR Programs may contribute to this measure by sharing documentation of reports or publications via email, presentation or webinar that present data or research findings from academic partners or other research that indicate findings that might affect public health.
Measure 10.2.4:
(S) Consultation or technical assistance provided to Tribal and local HDs and other public health system partners in applying relevant research results, evidence based and/or promising practices
Measure 10.2.4:
(S) Consultation or technical assistance provided to Tribal and local HDs and other public health system partners in applying relevant research results, evidence based and/or promising practices
HAI/AR Programs are encouraged to share knowledge, best practices and provide technical assistance to local/tribal partners/stakeholders on evidence-based HAI and AR prevention science and implementation best practices.
HAI/AR Programs are encouraged to share knowledge, best practices and provide technical assistance to local/tribal partners/stakeholders on evidence-based HAI and AR prevention science and implementation best practices.
Context: HDs must provide 2 examples of providing TA to local HDs or stakeholders/public health system partners in the application of research or evidence based/promising practices.
Opportunity: HAI/AR Programs may provide documentation of assistance in implementing HAI/AR prevention practices. This may include promoting evidence-based antibiotic stewardship interventions or implementation of CDC-recommended infection control and antibiotic stewardship strategies.
Context: HDs must provide 2 examples of providing TA to local HDs or stakeholders/public health system partners in the application of research or evidence based/promising practices.
Opportunity: HAI/AR Programs may provide documentation of assistance in implementing HAI/AR prevention practices. This may include promoting evidence-based antibiotic stewardship interventions or implementation of CDC-recommended infection control and antibiotic stewardship strategies.